ANGO Quote, Financials, Valuation and Earnings

Perspective Therapeutics has a net margin of -6.12% compared to AngioDynamics's net margin of --. AngioDynamics's return on equity of -20.83% beat Perspective Therapeutics's return on equity of --.

AngioDynamics has a consensus price target of $15.67, signalling upside risk potential of 68.64%. On the other hand Perspective Therapeutics has an analysts' consensus of $14.39 which suggests that it could grow by 638.1%. Given that Perspective Therapeutics has higher upside potential than AngioDynamics, analysts believe Perspective Therapeutics is more attractive than AngioDynamics.

AngioDynamics has a beta of 0.521, which suggesting that the stock is 47.938% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.199, suggesting its more volatile than the S&P 500 by 19.866%.

AngioDynamics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AngioDynamics pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

AngioDynamics quarterly revenues are $72M, which are larger than Perspective Therapeutics quarterly revenues of --. AngioDynamics's net income of -$4.4M is higher than Perspective Therapeutics's net income of -$40.2M. Notably, AngioDynamics's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics is 1.34x versus 12.62x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

Merit Medical Systems has a net margin of -6.12% compared to AngioDynamics's net margin of 7.87%. AngioDynamics's return on equity of -20.83% beat Merit Medical Systems's return on equity of 9.36%.

AngioDynamics has a consensus price target of $15.67, signalling upside risk potential of 68.64%. On the other hand Merit Medical Systems has an analysts' consensus of $117.82 which suggests that it could grow by 28.01%. Given that AngioDynamics has higher upside potential than Merit Medical Systems, analysts believe AngioDynamics is more attractive than Merit Medical Systems.

AngioDynamics has a beta of 0.521, which suggesting that the stock is 47.938% less volatile than S&P 500. In comparison Merit Medical Systems has a beta of 0.846, suggesting its less volatile than the S&P 500 by 15.356%.

AngioDynamics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Merit Medical Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AngioDynamics pays -- of its earnings as a dividend. Merit Medical Systems pays out -- of its earnings as a dividend.

AngioDynamics quarterly revenues are $72M, which are smaller than Merit Medical Systems quarterly revenues of $355.2M. AngioDynamics's net income of -$4.4M is lower than Merit Medical Systems's net income of $27.9M. Notably, AngioDynamics's price-to-earnings ratio is -- while Merit Medical Systems's PE ratio is 45.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics is 1.34x versus 4.03x for Merit Medical Systems. Usually stocks with elevated PS ratios are considered overvalued.

ResMed has a net margin of -6.12% compared to AngioDynamics's net margin of 26.88%. AngioDynamics's return on equity of -20.83% beat ResMed's return on equity of 25.56%.

AngioDynamics has a consensus price target of $15.67, signalling upside risk potential of 68.64%. On the other hand ResMed has an analysts' consensus of $267.15 which suggests that it could grow by 24.85%. Given that AngioDynamics has higher upside potential than ResMed, analysts believe AngioDynamics is more attractive than ResMed.

AngioDynamics has a beta of 0.521, which suggesting that the stock is 47.938% less volatile than S&P 500. In comparison ResMed has a beta of 0.755, suggesting its less volatile than the S&P 500 by 24.514%.

AngioDynamics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.97% to investors and pays a quarterly dividend of $0.53 per share. AngioDynamics pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

AngioDynamics quarterly revenues are $72M, which are smaller than ResMed quarterly revenues of $1.3B. AngioDynamics's net income of -$4.4M is lower than ResMed's net income of $344.6M. Notably, AngioDynamics's price-to-earnings ratio is -- while ResMed's PE ratio is 25.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics is 1.34x versus 6.41x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.

Retractable Technologies has a net margin of -6.12% compared to AngioDynamics's net margin of -18.58%. AngioDynamics's return on equity of -20.83% beat Retractable Technologies's return on equity of -16.83%.

AngioDynamics has a consensus price target of $15.67, signalling upside risk potential of 68.64%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that AngioDynamics has higher upside potential than Retractable Technologies, analysts believe AngioDynamics is more attractive than Retractable Technologies.

AngioDynamics has a beta of 0.521, which suggesting that the stock is 47.938% less volatile than S&P 500. In comparison Retractable Technologies has a beta of 2.279, suggesting its more volatile than the S&P 500 by 127.852%.

AngioDynamics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AngioDynamics pays -- of its earnings as a dividend. Retractable Technologies pays out -1.94% of its earnings as a dividend.

AngioDynamics quarterly revenues are $72M, which are larger than Retractable Technologies quarterly revenues of $10.3M. AngioDynamics's net income of -$4.4M is lower than Retractable Technologies's net income of -$1.9M. Notably, AngioDynamics's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics is 1.34x versus 0.62x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.